| 000 | 03379nam a22004815i 4500 | ||
|---|---|---|---|
| 001 | 978-981-97-9519-2 | ||
| 003 | DE-He213 | ||
| 005 | 20251030114913.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 241231s2024 si | s |||| 0|eng d | ||
| 020 |
_a9789819795192 _9978-981-97-9519-2 |
||
| 024 | 7 |
_a10.1007/978-981-97-9519-2 _2doi |
|
| 050 | 4 | _aRC799-869 | |
| 072 | 7 |
_aMNG _2bicssc |
|
| 072 | 7 |
_aMED031000 _2bisacsh |
|
| 072 | 7 |
_aMNG _2thema |
|
| 245 | 1 | 0 |
_aMetabolic Dysfunction-Associated Steatotic Liver Disease _h[electronic resource] : _bPrevalence, research insights and the future directions / _cedited by Nahum Méndez-Sánchez, Xingshun Qi. |
| 250 | _a1st ed. 2024. | ||
| 264 | 1 |
_aSingapore : _bSpringer Nature Singapore : _bImprint: Springer, _c2024. |
|
| 300 |
_aVIII, 170 p. 26 illus., 25 illus. in color. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 505 | 0 | _a -- Chapter 1 Introduction of MAFLD/MASLD. -- Chapter 2 UNVEILING THE MAFLD/MASLD EPIDEMIC. -- Chapter 3 Decoding MAFLD’s pathophysiology. -- Chapter 4 Liver Steatosis: From Lipotoxicity to Cellular Damage. -- Chapter 5 Diagnostic Advances in MAFLD/MASLD. -- Chapter 6 Histopathology of MAFLD/MASLD: insights into liver tissue changes. -- Chapter 7 MAFLD as a multisystemic disease. -- Chapter 8 MASLD and Hepatic/Extrahepatic Cancers Understanding the Complex Relationship. -- Chapter 9 Current Standards in Therapeutic Management. -- Chapter 10 REVOLUTIONARY BREAKTHROUGHS. -- Chapter 11 Integrative Approaches to MAFLD/MASLD Management. -- Chapter 12 MAFLD/MASLD IN SPECIAL POPULATIONS. -- Chapter 13 Looking ahead. -- Chapter 14 METABOLIC STEATOHEPATITIS AFTER LIVER TRANSPLANTATION. | |
| 520 | _aThis book provides crucial insights into the most recent advancements in understanding pathophysiology of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), and presents innovative treatment approaches. The emerging areas of study and potential avenues for further investigation are discussed in chapters. Additionally, the latest information on diagnostic tools, lifestyle interventions, and pharmacological treatments is also presented. With the worldwide prevalence of MASLD on the rise, it helps to equip medical professionals (hepatologists, gastroenterologists, endocrinologists, cardiologists, nephrologists, internists, and surgeons), researchers, and patients with up-to-date knowledge to effectively combat this multifaceted condition. | ||
| 650 | 0 |
_aGastroenterology. _976519 |
|
| 650 | 1 | 4 |
_aGastroenterology. _976519 |
| 700 | 1 |
_aMéndez-Sánchez, Nahum. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _989967 |
|
| 700 | 1 |
_aQi, Xingshun. _eeditor. _4edt _4http://id.loc.gov/vocabulary/relators/edt _989968 |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer Nature eBook | |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819795185 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819795208 |
| 776 | 0 | 8 |
_iPrinted edition: _z9789819795215 |
| 856 | 4 | 0 | _uhttps://doi.org/10.1007/978-981-97-9519-2 |
| 912 | _aZDB-2-SME | ||
| 912 | _aZDB-2-SXM | ||
| 999 |
_c66239 _d66239 |
||